Mckesson (MCK) Cash & Equivalents Growth (1y) (2010 - 2026)
Mckesson (MCK) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Akso Health |
2,315,158.81 Bn |
2,315,158.63 Bn |
- |
106.91% |
| 2 |
Mckesson |
92.76 Bn |
89.18 Bn |
4.04 Bn |
-30.15% |
| 3 |
Cencora |
52.82 Bn |
50.83 Bn |
3.59 Bn |
10.03% |
| 4 |
Cardinal Health |
52.17 Bn |
48.39 Bn |
2.50 Bn |
18.37% |
| 5 |
Henry Schein |
9.19 Bn |
9.71 Bn |
1.07 Bn |
8.66% |
| 6 |
Accendra Health |
246.88 Mn |
-90.00 Mn |
312.39 Mn |
466.79% |
| 7 |
Edap Tms |
161.92 Mn |
146.92 Mn |
8.15 Mn |
-39.13% |
| 8 |
111 |
107.47 Mn |
25.61 Mn |
23.58 Mn |
11.94% |
| 9 |
Cosmos Health |
9.42 Mn |
7.26 Mn |
1.38 Mn |
-30.72% |
| 10 |
Cellyan Biotechnology |
5.69 |
-2.48 Mn |
- |
-47.69% |
| Date | Value |
|---|
| Mar 31, 2026 |
-30.15% |
| Dec 31, 2025 |
161.63% |
| Sep 30, 2025 |
59.59% |
| Jun 30, 2025 |
5.04% |
| Mar 31, 2025 |
24.18% |
| Dec 31, 2024 |
-42.94% |
| Sep 30, 2024 |
-0.59% |
| Jun 30, 2024 |
-12.67% |
| Mar 31, 2024 |
-2.03% |
| Dec 31, 2023 |
-28.55% |
| Sep 30, 2023 |
-13.44% |
| Jun 30, 2023 |
18.05% |
| Mar 31, 2023 |
32.45% |
| Dec 31, 2022 |
0.73% |
| Sep 30, 2022 |
35.56% |
| Jun 30, 2022 |
-7.84% |
| Mar 31, 2022 |
-43.74% |
| Dec 31, 2021 |
-23.01% |
| Sep 30, 2021 |
-30.41% |
| Jun 30, 2021 |
-7.27% |
